Jeff MacKeigan is a Professor in the Department of Pediatrics & Human Development, and Assistant Dean for Research at the College of Human Medicine. His research focuses on signaling pathways important for cancer cell growth and survival, with the goal of informing new treatment strategies.
Dr. MacKeigan received his Ph.D. in Microbiology and Immunology at the University of North Carolina Comprehensive Cancer Center. He completed his postdoctoral training at Harvard Medical School with fellowship funding from the American Cancer Society. Prior to joining MSU, Dr. MacKeigan held positions at Novartis Institutes for Biomedical Research and Van Andel Research Institute.
Dr. MacKeigan’s research investigates the cell signaling networks that encompass autophagy, the mTOR pathway, and cancer metabolism. The MacKeigan Lab uses a variety of cutting-edge technologies, combined with tumor biology expertise and pathway knowledge to study complex diseases. All of Dr. MacKeigan’s research projects have one common goal - to identify novel therapeutic targets.